United States Glucosamine Supplements Market Size & Outlook, 2026-2034
United States Glucosamine Supplements Market Insights
- As per Deep Market Insights insights, the United States Glucosamine Supplements Market stood at USD 28.83 billion in 2025 and is anticipated to grow to USD 55.85 billion by 2034.
- The United States market is expected to advance at a CAGR of 7.72% from 2026 through 2034.
- In 2025, Capsule accounted for the highest share of the By Type market size.
- During the forecast period, Pill is set to register the highest growth, making it the most lucrative By Type segment.
Source: DMI Analysis Company Publications, Primary Interviews.
Other Key Findings
- In 2025, United States accounted for 21.57% of the global Glucosamine Supplements Market size.
- By 2034, United States is expected to lead the global Glucosamine Supplements Market in terms of market size.
- Within North America, United States is projected to dominate the regional Glucosamine Supplements Market size by 2034.
- United States is identified as the fastest-growing market in North America, anticipated to reach USD 56.3 billion by 2034.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2025 |
| Study Period | 2022-2034 |
| Historical Period | 2022-2024 |
| Forecast Period | 2026-2034 |
| Market Size In 2025 | USD 28.83 billion |
| Market Size In 2034 | USD 55.85 billion |
| Largest segment | Capsule |
| Units | Revenue in USD billion |
| CAGR | 7.72% (2026-2034) |
| Segmnetation Covered | |
| By Type |
|
| By Application |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
United States Glucosamine Supplements Market By Type 2026-2034 (USD billion)
| By Type | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capsule | XX.x | XX.x | XX.x | 18.7 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Pill | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
United States Glucosamine Supplements Market By Application 2026-2034 (USD billion)
| By Application | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Osteoarthritis | XX.x | XX.x | XX.x | 16.81 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Nutritional Dietary Supplements | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.